Donor and recipient specific tolerance in cells from semi-allogeneic, H-2 subregion compatible or fully allogeneic bone marrow chimeras attributable to clonal deletion. 1989

K Onoé, and K Iwabuchi, and C Iwabuchi, and H Arase, and S Hatakeyama, and P P Wambua, and N Fukushi, and I Negishi, and R A Good, and K Ogasawara
Section of Pathology, Institute of Immunological Science, Hokkaido University, Sapporo, Japan.

Specificities of tolerance induced in allogeneic bone marrow (BM) chimeras which had been established by injecting allogeneic BM cells pretreated with anti-Thy-1 mAb alone (without complement (C)) were analyzed using Simonsen's splenomegaly assay. Lymphocytes from fully allogeneic, semi-allogeneic and H-2 subregion compatible BM chimeras were specifically unresponsive to donor and recipient antigens (Ag). However, cells from H-2 subregion compatible chimeras initiated as vigorously a GVHR in F1 recipient mice, which were disparate at H-2K and I-A regions, as did spleen cells of donor mice, which were incompatible at the entire H-2 and minor histocompatibility regions of the recipients. The donor cells from such chimeras that initiated these considerable GVHR were either CD4+ or CD8+ T cells. Furthermore, synergistic effects by the CD4+ and CD8+ T lymphocytes were also observed. We found no evidence for a suppressive mechanism(s) in maintenance of the specific tolerance in allogeneic chimeras. Further, when lymphoid cells from these chimeras were adoptively transferred to irradiated mice of the donor strain and maintained for 5 days in the absence of recipient Ag (tolerogen), the adoptively transferred cells were shown to retain their unresponsiveness to the recipient Ag. These results reveal that T lymphocytes from allogeneic BM chimeras prepared by our method had been specifically induced to a tolerant state to both donor and recipient Ag and that the major mechanism of induction and maintenance of long-lasting tolerance is attributable to clonal deletion of both CD4+ and CD8+ T cell subsets rather than to the development of a population of suppressor cells of any sort.

UI MeSH Term Description Entries
D007108 Immune Tolerance The specific failure of a normally responsive individual to make an immune response to a known antigen. It results from previous contact with the antigen by an immunologically immature individual (fetus or neonate) or by an adult exposed to extreme high-dose or low-dose antigen, or by exposure to radiation, antimetabolites, antilymphocytic serum, etc. Immunosuppression (Physiology),Immunosuppressions (Physiology),Tolerance, Immune
D007116 Immunization, Passive Transfer of immunity from immunized to non-immune host by administration of serum antibodies, or transplantation of lymphocytes (ADOPTIVE TRANSFER). Convalescent Plasma Therapy,Immunoglobulin Therapy,Immunotherapy, Passive,Normal Serum Globulin Therapy,Passive Antibody Transfer,Passive Transfer of Immunity,Serotherapy,Passive Immunotherapy,Therapy, Immunoglobulin,Antibody Transfer, Passive,Passive Immunization,Therapy, Convalescent Plasma,Transfer, Passive Antibody
D007118 Immunoassay A technique using antibodies for identifying or quantifying a substance. Usually the substance being studied serves as antigen both in antibody production and in measurement of antibody by the test substance. Immunochromatographic Assay,Assay, Immunochromatographic,Assays, Immunochromatographic,Immunoassays,Immunochromatographic Assays
D008815 Mice, Inbred Strains Genetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations, or by parent x offspring matings carried out with certain restrictions. All animals within an inbred strain trace back to a common ancestor in the twentieth generation. Inbred Mouse Strains,Inbred Strain of Mice,Inbred Strain of Mouse,Inbred Strains of Mice,Mouse, Inbred Strain,Inbred Mouse Strain,Mouse Inbred Strain,Mouse Inbred Strains,Mouse Strain, Inbred,Mouse Strains, Inbred,Strain, Inbred Mouse,Strains, Inbred Mouse
D001853 Bone Marrow The soft tissue filling the cavities of bones. Bone marrow exists in two types, yellow and red. Yellow marrow is found in the large cavities of large bones and consists mostly of fat cells and a few primitive blood cells. Red marrow is a hematopoietic tissue and is the site of production of erythrocytes and granular leukocytes. Bone marrow is made up of a framework of connective tissue containing branching fibers with the frame being filled with marrow cells. Marrow,Red Marrow,Yellow Marrow,Marrow, Bone,Marrow, Red,Marrow, Yellow
D001854 Bone Marrow Cells Cells contained in the bone marrow including fat cells (see ADIPOCYTES); STROMAL CELLS; MEGAKARYOCYTES; and the immediate precursors of most blood cells. Bone Marrow Cell,Cell, Bone Marrow,Cells, Bone Marrow,Marrow Cell, Bone,Marrow Cells, Bone
D002469 Cell Separation Techniques for separating distinct populations of cells. Cell Isolation,Cell Segregation,Isolation, Cell,Cell Isolations,Cell Segregations,Cell Separations,Isolations, Cell,Segregation, Cell,Segregations, Cell,Separation, Cell,Separations, Cell
D002678 Chimera An individual that contains cell populations derived from different zygotes. Hybrids,Chimeras,Hybrid
D005434 Flow Cytometry Technique using an instrument system for making, processing, and displaying one or more measurements on individual cells obtained from a cell suspension. Cells are usually stained with one or more fluorescent dyes specific to cell components of interest, e.g., DNA, and fluorescence of each cell is measured as it rapidly transverses the excitation beam (laser or mercury arc lamp). Fluorescence provides a quantitative measure of various biochemical and biophysical properties of the cell, as well as a basis for cell sorting. Other measurable optical parameters include light absorption and light scattering, the latter being applicable to the measurement of cell size, shape, density, granularity, and stain uptake. Cytofluorometry, Flow,Cytometry, Flow,Flow Microfluorimetry,Fluorescence-Activated Cell Sorting,Microfluorometry, Flow,Cell Sorting, Fluorescence-Activated,Cell Sortings, Fluorescence-Activated,Cytofluorometries, Flow,Cytometries, Flow,Flow Cytofluorometries,Flow Cytofluorometry,Flow Cytometries,Flow Microfluorometries,Flow Microfluorometry,Fluorescence Activated Cell Sorting,Fluorescence-Activated Cell Sortings,Microfluorimetry, Flow,Microfluorometries, Flow,Sorting, Fluorescence-Activated Cell,Sortings, Fluorescence-Activated Cell
D006087 Graft vs Host Reaction An immunological attack mounted by a graft against the host because of HISTOINCOMPATIBILITY when immunologically competent cells are transplanted to an immunologically incompetent host; the resulting clinical picture is that of GRAFT VS HOST DISEASE. HLA Sensitization,Human Leukocyte Antigen Sensitization,Sensitization, HLA

Related Publications

K Onoé, and K Iwabuchi, and C Iwabuchi, and H Arase, and S Hatakeyama, and P P Wambua, and N Fukushi, and I Negishi, and R A Good, and K Ogasawara
January 1994, Transplant international : official journal of the European Society for Organ Transplantation,
K Onoé, and K Iwabuchi, and C Iwabuchi, and H Arase, and S Hatakeyama, and P P Wambua, and N Fukushi, and I Negishi, and R A Good, and K Ogasawara
June 1989, European journal of immunology,
K Onoé, and K Iwabuchi, and C Iwabuchi, and H Arase, and S Hatakeyama, and P P Wambua, and N Fukushi, and I Negishi, and R A Good, and K Ogasawara
June 1990, The Journal of surgical research,
K Onoé, and K Iwabuchi, and C Iwabuchi, and H Arase, and S Hatakeyama, and P P Wambua, and N Fukushi, and I Negishi, and R A Good, and K Ogasawara
November 1988, Journal of immunology (Baltimore, Md. : 1950),
K Onoé, and K Iwabuchi, and C Iwabuchi, and H Arase, and S Hatakeyama, and P P Wambua, and N Fukushi, and I Negishi, and R A Good, and K Ogasawara
December 1999, Journal of immunology (Baltimore, Md. : 1950),
K Onoé, and K Iwabuchi, and C Iwabuchi, and H Arase, and S Hatakeyama, and P P Wambua, and N Fukushi, and I Negishi, and R A Good, and K Ogasawara
January 1989, Thymus,
K Onoé, and K Iwabuchi, and C Iwabuchi, and H Arase, and S Hatakeyama, and P P Wambua, and N Fukushi, and I Negishi, and R A Good, and K Ogasawara
July 1990, Journal of immunology (Baltimore, Md. : 1950),
K Onoé, and K Iwabuchi, and C Iwabuchi, and H Arase, and S Hatakeyama, and P P Wambua, and N Fukushi, and I Negishi, and R A Good, and K Ogasawara
May 1999, Journal of pediatric surgery,
K Onoé, and K Iwabuchi, and C Iwabuchi, and H Arase, and S Hatakeyama, and P P Wambua, and N Fukushi, and I Negishi, and R A Good, and K Ogasawara
May 1981, Clinical immunology and immunopathology,
K Onoé, and K Iwabuchi, and C Iwabuchi, and H Arase, and S Hatakeyama, and P P Wambua, and N Fukushi, and I Negishi, and R A Good, and K Ogasawara
April 1987, Journal of immunology (Baltimore, Md. : 1950),
Copied contents to your clipboard!